Form 4: Innoviva Director Mark DiPaolo Acquires Shares and Options Following Annual Meeting

Director Mark DiPaolo reports acquisition of Innoviva shares and options following the company's 2025 annual meeting of stockholders.

Summary

• Mark DiPaolo, a director of Innoviva, Inc., filed a Form 4 disclosing changes in beneficial ownership.
• On May 19, 2025, DiPaolo acquired 12,077 shares of common stock and 10,000 non-statutory stock options.
• The shares were acquired at a price of $0.
• The options have an exercise price of $18.63 and expire on May 18, 2035.
• Following the transaction, DiPaolo directly owns 130,706 shares of common stock and 10,000 derivative securities.
• The restricted stock units (RSUs) and options vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, contingent upon continuous service as an Outside Director.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The director's acquisition of shares and options suggests confidence in the company, but it's a routine transaction.

Positives

• The acquisition of shares and options by a director signals confidence in the company's future prospects.

Future Outlook

The vesting of the RSUs and options is contingent upon the director's continued service, incentivizing their ongoing commitment to the company.

Industry Context

Form 4 filings are standard disclosures for corporate insiders and provide transparency into their transactions in the company's securities. This filing indicates director DiPaolo's continued investment in Innoviva.

Stakeholder Impact

• The director's acquisition of shares could be viewed positively by shareholders, signaling alignment of interests.

Key Dates

Keywords

Innoviva, Director, DiPaolo, Stock Options, Form 4, Beneficial Ownership, Securities, INVA, RSUs